China Universal Asset Management Company’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.1K | Buy |
62,190
+5,339
| +9% | +$6.62K | 0.01% | 385 |
|
|
2025
Q1 | $67.1K | Sell |
56,851
-3,137
| -5% | -$3.7K | 0.01% | 392 |
|
|
2024
Q4 | $110K | Buy |
59,988
+5,653
| +10% | +$10.3K | 0.01% | 380 |
|
|
2024
Q3 | $92.4K | Buy |
54,335
+20,417
| +60% | +$34.7K | 0.01% | 362 |
|
|
2024
Q2 | $46.5K | Sell |
33,918
-19,530
| -37% | -$26.8K | 0.01% | 362 |
|
|
2024
Q1 | $200K | Buy |
53,448
+20,593
| +63% | +$77.2K | 0.03% | 288 |
|
|
2023
Q4 | $322K | Buy |
32,855
+12,628
| +62% | +$124K | 0.06% | 169 |
|
|
2023
Q3 | $169K | Buy |
20,227
+3,149
| +18% | +$26.3K | 0.05% | 156 |
|
|
2023
Q2 | $227K | Sell |
17,078
-73
| -0.4% | -$971 | 0.07% | 126 |
|
|
2023
Q1 | $199K | Buy |
17,151
+1,051
| +7% | +$12.2K | 0.07% | 117 |
|
|
2022
Q4 | $132K | Buy |
16,100
+13,995
| +665% | +$114K | 0.05% | 114 |
|
|
2022
Q3 | $12K | Buy |
+2,105
| New | +$12K | 0.01% | 187 |
|